Research Article
circSLC30A7 Inhibits Hepatocellular Carcinoma Cell Proliferation via the miR-767-5p/FBXW7/NOTCH1 Axis
Table 1
The relationship between the expression of circSLC30A7 and the clinical characteristics of HCC patients.
| Characteristics | Number | circSLC30A7 expression | P value | High group | Low group |
| Age (years) | <60 | 14 | 5 | 9 | 0.207 | ≥60 | 36 | 20 | 16 |
| Gender | Male | 27 | 13 | 14 | 0.776 | Female | 23 | 12 | 11 |
| Size (cm) | <5 | 23 | 15 | 8 | 0.047 | ≥5 | 27 | 10 | 17 |
| Stage | I/II | 21 | 14 | 7 | 0.044 | III/IV | 29 | 11 | 18 |
| Differentiation grade | Well + moderate | 26 | 13 | 13 | 0.999 | Poor | 24 | 12 | 12 |
| Metastasis | Absent | 28 | 15 | 13 | 0.568 | Present | 22 | 10 | 12 |
|
|
, statistically significant difference. |